Sign in

CIK 0000921299

  • Non-accelerated filer
  • Smaller reporting company

KYNTRA BIO, INC.

Sign in to watch
Ticker
KYNB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
770357827
Phone
+1 415-978-1200
Business address
350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
Former names
FIBROGEN INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-10-07 Kurkijarvi Kalevi Director Exercise or conversion · Stock Option (Right to Buy) −6,000 6,000
2019-09-20 Chung Christine SVP, China Operations Exercise or conversion +5,625 $19.39 $109K 145,253
2019-09-20 Chung Christine SVP, China Operations Sale −5,625 $39.87 $224K 139,628
2019-09-20 Chung Christine SVP, China Operations Exercise or conversion · Stock Option (Right to Buy) −5,625 45,209
2019-09-19 Chung Christine SVP, China Operations Exercise or conversion +2,120 $19.39 $41K 145,253
2019-09-19 Chung Christine SVP, China Operations Sale −2,225 $40.00 $89K 143,028
2019-09-19 Chung Christine SVP, China Operations Sale −3,400 $40.75 $139K 139,628
2019-09-19 Chung Christine SVP, China Operations Exercise or conversion · Stock Option (Right to Buy) −2,120 50,834
2019-09-18 Schoeneck James A Interim CEO Grant or award +57,300 62,000
2019-09-18 Schoeneck James A Interim CEO Grant or award · Stock Option (Right to Buy) +97,100 97,100
2019-09-17 Cotroneo Pat SVP, Finance and CFO Sale −3,201 $41.38 $132K 244,432
2019-09-16 Yu K Peony Chief Medical Officer Sale −3,419 $40.92 $140K 175,240
2019-09-09 Kurkijarvi Kalevi Director Exercise or conversion +6,000 $5.95 $36K 34,400
2019-09-09 Kurkijarvi Kalevi Director Sale −5,580 $40.90 $228K 28,820
2019-09-09 Kurkijarvi Kalevi Director Sale −420 $41.67 $18K 28,400
2019-09-09 Kurkijarvi Kalevi Director Exercise or conversion · Stock Option (Right to Buy) −6,000 0
2019-09-06 Yu K Peony Chief Medical Officer Shares withheld for taxes −8,317 $41.68 $347K 178,659
2019-09-06 Kouchakji Elias SVP, Clinical Dev, Drug Safety Shares withheld for taxes −5,541 $41.68 $231K 103,658
2019-09-06 Cotroneo Pat SVP, Finance and CFO Shares withheld for taxes −3,144 $41.68 $131K 247,633
2019-09-06 Chung Christine SVP, China Operations Shares withheld for taxes −8,437 $41.68 $352K 143,133

Page 27 of 33 · 651 trades